Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Avonex was produced by Biogen Idec.

Elan hit by 'disaster' withdrawal

Both patients were involved in a trial that examined the effectiveness of Tysabri in combination with Biogen's existing MS drug, Avonex, on the market for nearly nine years.

Analysts back Tysabri return despite FDA concern

Tysabri was withdrawn a year ago after two patients taking it in combination with another Biogen MS drug, Avonex, developed a rare and often fatal brain infection known as progressive multifocal

Lectus wins USD 6.1m investment from Wellcome Trust

It is the fifth largest segment of the CNS market. The MS market is currently dominated by six treatments: Avonex (Biogen), Betaseron/Betaferon (Schering), Copaxone (Teva), Novatrone (Schering), Rebif (Serono/ Pfizer)

New accounts: May

Grandma Vines. Dermatology (consumer). hsdcommunications. Biogen Idec. Avonex. CNS. TVF Communications.

PM Society Award Winners 2006

Craft Award:Detailing Aid. Winner:Seven Stones for Avonex. Sponsor: Ashfield Healthcare. Craft Award:GP Direct Mail Campaign. ... Sponsor:Wiley Pharmafile. Craft Award:Hospital Campaign. Winner:Seven Stones for Avonex. Sponsor: TNS Healthcare.

[ Previous 5 results ] 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
Patients are ready for virtual clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...